NeuronesXPAR:NRO -0.43%91 Buyback Yield % is 0.04 as of Jul. 11, 2026. GuruFocus rates XPAR:NRO with a GF Score™ of 91/100 and a GF Value™ of €50.35 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,307 Software companies, Neurones ranks better than 58.91% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Neurones's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:NRO vs IBM, ACN, FISV: Buyback Yield % Comparison
For the Information Technology Services subindustry, Neurones's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones Buyback Yield % vs Software Industry
For the Software industry and Technology sector, Neurones's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Neurones's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neurones (XPAR:NRO) has a Buyback Yield % of 0.04 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Neurones and its competitors. According to the industry distribution chart, Neurones ranks #537 out of 1307 companies in the Software industry, placing it in the top 41.1%.
Is Neurones' Buyback Yield % too high?
Neurones' current Buyback Yield % is 0.04. Based on the distribution chart, Neurones ranks #537 out of 1307 companies in the Software industry, which is above the industry midpoint. Overall, Neurones has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Buyback Yield % compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #537 out of 1307 companies for Buyback Yield %. This puts Neurones in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Software company?
A good Buyback Yield % depends on the Software industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Neurones and its competitors. Neurones's current Buyback Yield % is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Significantly Undervalued. The stock's GF Value™ is €50.35, compared to a current price of €35.00 — trading 30.5% below its estimated fair value. The current Buyback Yield % is 0.04. Neurones' overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Buyback Yield % is 0.04 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €35.00 is trading 30.5% below its estimated GF Value™ of €50.35.
GuruFocus considers Neurones to be Significantly Undervalued.
Key valuation signals for XPAR:NRO:
Buyback Yield %: 0.04
GF Value™: €50.35 vs. price of €35.00 (30.5% below fair value)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
91GF Score
Get the complete analysis for XPAR:NRO
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
